Angiotensin-Converting Enzyme Inhibitor Is Associated with Decreased Survival in NSCLC Patients Treated with PD-1 Checkpoint Blockers

Affiliation auteurs!!!! Error affiliation !!!!
TitreAngiotensin-Converting Enzyme Inhibitor Is Associated with Decreased Survival in NSCLC Patients Treated with PD-1 Checkpoint Blockers
Type de publicationJournal Article
Year of Publication2019
AuteursMedjbar S., Richard C., Fumet J., Malo J., Elkrief A., Routy B., Boidot R., Truntzer C., Ghiringhelli F.
JournalJOURNAL OF THORACIC ONCOLOGY
Volume14
PaginationS678-S679
Date PublishedOCT
Type of ArticleMeeting Abstract
ISSN1556-0864
Mots-clésAngiotensin-converting enzyme inhibitor, Immune checkpoint inhibitor, NSCLC
DOI10.1016/j.jtho.2019.08.1440